Atara Biotherapeutics, Inc.

DB:AT20 Stock Report

Market Cap: €34.3m

Atara Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:AT20 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 May 24Buy€5,880,792Adamantem CapitalCompany322,636.92€18.23
16 May 24Sell€14,617Jill HenrichIndividual1,030€14.19
16 May 24Sell€16,262Eric HyllengrenIndividual1,145.92€14.19
16 May 24Sell€24,351Anhco NguyenIndividual1,715.96€14.19
16 May 24Sell€18,392K. MuruganIndividual1,296.04€14.19
16 May 24Sell€46,266Pascal TouchonIndividual3,260.24€14.19
04 Mar 24Sell€2,571Jill HenrichIndividual155.16€16.57
04 Mar 24Sell€16,469Pascal TouchonIndividual993.76€16.57
04 Mar 24Sell€4,429Eric HyllengrenIndividual267.16€16.60
04 Mar 24Sell€6,658K. MuruganIndividual401.76€16.57
04 Mar 24Sell€7,124Anhco NguyenIndividual429.84€16.57
16 Nov 23Sell€1,170Jill HenrichIndividual130.68€8.95
16 Nov 23Sell€4,282Eric HyllengrenIndividual478.32€8.95
16 Nov 23Sell€2,975K. MuruganIndividual332.28€8.95
16 Nov 23Sell€7,309Pascal TouchonIndividual816.36€8.95
16 Nov 23Sell€4,400Manher JoshiIndividual491.48€8.95
16 Nov 23Sell€3,171Anhco NguyenIndividual354.24€8.95
14 Nov 23Buy€62,853Carol GallagherIndividual10,800€7.14
10 Nov 23Buy€23,739William HeidenIndividual4,000€5.93
10 Nov 23Buy€94,976Eric DobmeierIndividual17,873€5.31
16 Aug 23Sell€5,071Jill HenrichIndividual133.84€37.91
16 Aug 23Sell€10,566Manher JoshiIndividual279€37.88
16 Aug 23Sell€13,136K. MuruganIndividual346.88€37.88
16 Aug 23Sell€22,915Anhco NguyenIndividual605.04€37.88
16 Aug 23Sell€46,600Pascal TouchonIndividual1,230.64€37.88
16 Aug 23Sell€12,400Eric HyllengrenIndividual327.44€37.91

Insider Trading Volume

Insider Buying: AT20 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of AT20?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2360.0049%
Individual Insiders104,3612.17%
VC/PE Firms322,6376.7%
General Public934,03219.4%
Hedge Funds1,037,69521.5%
Institutions2,417,68450.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.


Top Shareholders

Top 25 shareholders own 73.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.44%
EcoR1 Capital, LLC
406,681€2.9m0.99%0.1%
7.69%
Redmile Group, LLC
370,532€2.6m-10.1%0.14%
6.7%
Adamantem Capital
322,637€2.3m0%no data
5.67%
BlackRock, Inc.
273,259€1.9m-3.61%no data
5.46%
Bank of America Corporation, Asset Management Arm
263,212€1.9m3,380%no data
5.41%
Citadel Advisors LLC
260,482€1.9m2,380%no data
4.16%
The Vanguard Group, Inc.
200,517€1.4m-25%no data
4.12%
T. Rowe Price Group, Inc.
198,326€1.4m8,920%no data
3.45%
Tavistock Life Sciences
166,000€1.2m0%0.07%
2.33%
Vestal Point Capital, LP
112,000€798.6k0%0.08%
2.19%
Acadian Asset Management LLC
105,547€752.6k49.5%no data
2.18%
AQR Capital Management, LLC
104,904€748.0k-10.5%no data
2.07%
State Street Global Advisors, Inc.
99,561€709.9k-10.6%no data
1.79%
Geode Capital Management, LLC
86,343€615.6k0.39%no data
1.56%
Tang Capital Management, LLC
75,196€536.2k0%0.08%
1.56%
Kleiner Perkins Caufield & Byers
75,066€535.2k0%0.13%
1.47%
Woodline Partners LP
70,992€506.2k0%0.01%
1.12%
Morgan Stanley, Investment Banking and Brokerage Investments
53,730€383.1k-24.5%no data
1.01%
JP Morgan Asset Management
48,547€346.1k-40.1%no data
0.91%
Medical Strategy GmbH, Asset Management Arm
43,888€312.9k0%0.02%
0.83%
Staley Capital Advisers, Inc.
40,000€285.2k0%0.02%
0.82%
J. Goldman & Co., L.P.
39,466€281.4k0%0.02%
0.81%
Renaissance Technologies LLC
39,215€279.6k57.4%no data
0.74%
Checkpoint Capital, LLC, Asset Management Arm
35,714€254.6k0%0.21%
0.71%
Northern Trust Global Investments
34,032€242.7k0.64%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.